Eric Dobmeier

CIK: 0001202785

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

GPCR

Structure Therapeutics Inc.

Director

JANX

Janux Therapeutics, Inc.

Director

JBIO

Jade Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

GPCR
Structure Therapeutics Inc.
Jun 17, 2026
Award(A)
Share Option (right to buy)
Direct
39.5K shares-
JANX
Janux Therapeutics, Inc.
Jun 11, 2026
Award(A)
Direct
5.5K shares-
JBIO
Jade Biosciences, Inc.
Jun 9, 2026
Award(A)
Stock Option (Right to Buy)
Direct
34.8K shares-
GPCR
Structure Therapeutics Inc.
Jun 23, 2025
Award(A)
Share Option (right to buy)
Direct
51.8K shares-
JANX
Janux Therapeutics, Inc.
Jun 11, 2025
Award(A)
Direct
3.8K shares-
JBIO
Jade Biosciences, Inc.
Apr 29, 2025
Award(A)
Stock Option (Right to Buy)
Direct
23K shares-

		Type	Shares	Price		Ownership
Jun 17, 2026	GPCR Structure Therapeutics Inc.	Award(A) Share Option (right to buy)	39,453	-	-	Direct
Jun 11, 2026	JANX Janux Therapeutics, Inc.	Award(A)	5,500	-	$0	Direct
Jun 9, 2026	JBIO Jade Biosciences, Inc.	Award(A) Stock Option (Right to Buy)	34,843	-	-	Direct
Jun 23, 2025	GPCR Structure Therapeutics Inc.	Award(A) Share Option (right to buy)	51,804	-	-	Direct
Jun 11, 2025	JANX Janux Therapeutics, Inc.	Award(A)	3,750	-	-	Direct
Apr 29, 2025	JBIO Jade Biosciences, Inc.	Award(A) Stock Option (Right to Buy)	23,017	-	-	Direct

1-6 of 6 transactions

About DOBMEIER ERIC

DOBMEIER ERIC (SEC CIK 0001202785) files insider reports with the SEC as Director of Structure Therapeutics Inc. (GPCR), Director of Janux Therapeutics, Inc. (JANX) and Director of Jade Biosciences, Inc. (JBIO).

Signal8 holds 7 ownership filings by DOBMEIER ERIC (1 Form 3, 6 Form 4), filed between May 1, 2025 and Jun 18, 2026. Those filings report 6 transactions, from Apr 29, 2025 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on DOBMEIER ERIC's filings is in WALTHAM, MA.

Recent filings by DOBMEIER ERIC

Jun 17, 2026: Grant or award of GPCR derivative securities (Form 4, code A).
Jun 11, 2026: Grant or award of JANX shares (Form 4, code A).
Jun 9, 2026: Grant or award of JBIO derivative securities (Form 4, code A).
Jun 23, 2025: Grant or award of GPCR derivative securities (Form 4, code A).
Jun 11, 2025: Grant or award of JANX shares (Form 4, code A).

Other insiders filing for Structure Therapeutics Inc. (GPCR)

Coll Crespo Blas, CHIEF MEDICAL OFFICER
Lin Xichen, CHIEF SCIENTIFIC OFFICER
Berrios John Joseph, Chief Commercial Officer
FMR LLC, 10% Owner
Russell Angus C., Director
LOVE TED W, Director

How to read Form 4 transaction codes